OCX fundamentals
An in-depth look to Oncocyte Corporation operating, investing, and financing activities
OCX free cash flow for Q4 23 is -4.83 M USD. For 2023, OCX free cash flow was -23.61 M USD and operating cash flow was -23.32 M USD.
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM